JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Ladanyi
    Ladanyi
  2. Berger
    Berger
  3. Arcila
    Arcila
  4. Drilon
    Drilon
  5. Solit
    Solit
  6. Mandelker
    Mandelker
  7. Riely
    Riely
  8. Shia
    Shia
  9. Stadler
    Stadler
  10. Weigelt
    Weigelt

Groups

  1. Department of Pathology and Laboratory Medicine (79)
  2. Department of Medicine (65)
  3. Solid Tumor Oncology Division (61)
  4. GSK Faculty (59)
  5. Human Oncology and Pathogenesis Program (48)
  6. Tow Center for Developmental Oncology (TCDO) (38)
  7. Weinberg Fellows (38)
  8. Sloan Kettering Institute Postdocs (34)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (30)
  10. Population Sciences Research Program (28)
Search Within
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (77)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (79)
  2. Department of Medicine (65)
  3. Solid Tumor Oncology Division (61)
  4. GSK Faculty (59)
  5. Human Oncology and Pathogenesis Program (48)
  6. Tow Center for Developmental Oncology (TCDO) (38)

More Groups

People
  1. Marc Ladanyi (24)
  2. Michael Berger (20)
  3. Ahmet Zehir (16)
  4. Alexander Drilon (14)
  5. David Solit (14)
  6. Maria Arcila (14)

More People

Years
  1. 2025 (2)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (12)
  5. 2021 (10)
  6. 2020 (8)

More Years

Publishers
  1. American Society of Clinical Oncology (79)

Results (79)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Retrospective analysis of BRCA-altered uterine sarcoma treated with poly(ADP-ribose) polymerase inhibitors
    Journal Article

    Rao, M.; Merrill, M.; Troxel, M.; Chiang, S.; Momeni-Boroujeni, A.; Hensley, M. L.; Schram, A. M.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Clinical activity of mitogen-activated protein kinase inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers
    Review

    Dankner, M.; Rousselle, E.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Lazaratos, A. M.; Vincent Rajadurai, C.; Stein, A. J. B.; Bian, D.; Tai, P.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • DNA methylation classes of stage II and III primary melanomas and their clinical and prognostic significance
    Journal Article

    Conway, K.; Edmiston, S. N.; Vondras, A.; Reiner, A.; Corcoran, D. L.; Shen, R.; Parrish, E. A.; Hao, H.; Lin, L.; Kenney, J. M.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Response to crizotinib after entrectinib resistance in ROS1-rearranged, MET-amplified lung adenocarcinoma
    Journal Article

    Vaz, V. R.; Gandhi, M. M.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Ladanyi, M.; Vanderbilt, C.; Pecci, F.; Aldea, M.; Barrichello, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma
    Journal Article

    McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Consideration of a novel surgical approach in the management of gastric adenocarcinoma and proximal polyposis syndrome
    Journal Article

    Judge, S. J.; Gearty, S. V.; Catchings, A.; Ranganathan, M.; Roehrl, M. H.; Vardhana, S. A.; Tang, L.; Stadler, Z. K.; Strong, V. E.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • PD-L1 immunohistochemistry in gastric cancer: Comparison of combined positive score and tumor area positivity across 28-8, 22C3, and SP263 assays
    Journal Article

    Klempner, S. J.; Cowden, E. S.; Cytryn, S. L.; Fassan, M.; Kawakami, H.; Shimada, H.; Tang, L. H.; Wagner, D. C.; Yatabe, Y.; Savchenko, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-only sequencing: A story only half told
    Editorial

    Ceyhan-Birsoy, O.; Stadler, Z. K.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Modeling extraordinary response through targeting secondary alterations in fusion-associated sarcoma
    Journal Article

    Vanoli, F.; Song, E.; Dermawan, J. K.; Fishinevich, E.; Sung, P.; Min, S. S.; Xie, Z.; de Traux de Wardin, H.; Hwang, S.; Maki, R. G.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology